fda glp-1 compounding crackdown september 2025 2, 2025: U.S. restrictions have stemmed a flood of compounded semaglutide and tirzepatide – Partnership for Safe Medicines FDA GLP-1 Compounding Crackdown

For those without pre-existing pancreatic disease, GLP-1 medications are considered to have a favorable safety profile, with pancreatitis being rare and not definitively proven to increase in well-controlled trial data. David Cutler, MD Cutler said that for most people, the absolute risk of experiencing pancreatitis will be very low

Zunz E, Barre JL (1929) Contributions A L'tude des Variations Physiologiques De la Scrtion Interne Du Pancras

PpGST1 activated by PpMYB10.1 participates in anthocyanin accumulation in peach (Zhao et al., 2020)

A FAIR Health analysis found a nearly 600% rise in patients using GLP-1s for weight loss over six years, reaching over 2% of the population ( [2] ), even as total GLP-1 usage (for any indication) approached 4% of Americans (driven roughly half by weight-loss vs diabetes) ( [2] )

Glutathione is a powerful brightening ingredient that works by preventing excess melanin build up